Deal Library / Pharma BD Deal Intelligence

Watson Pharmaceuticals Inc. — Pharma Deals

The Pharma Closeout tracks 4 deals, $4.6B in disclosed deal value, 4 with a post-close Outcome Score for Watson Pharmaceuticals Inc..

Median Critic Score: 69  ·  Median Outcome Score: 65

Best outcome: Watson Pharmaceuticals Inc. / Amarin Development AB (Amarin Corp subsidiary) (70)  ·  Weakest outcome: Watson Pharmaceuticals Inc. / Andrx Corporation (62)

All 4 deals

• Watson Pharmaceuticals Inc. / Amarin Development AB (Amarin Corp subsidiary) — 2003 · $150M · Largely worked — most objectives met.
• Watson Pharmaceuticals Inc. / Andrx Corporation — 2006 · $1.9B · Largely worked — most objectives met.
• Watson Pharmaceuticals Inc. / Schein Pharmaceutical Inc. — 2000 · $674M · Largely worked — most objectives met.
• Watson Pharmaceuticals Inc. / Andrx Corporation — 2007 · $1.9B · Largely worked — most objectives met.

← Deal Library  ·  Interactive search  ·  How we score deals